Drug intelligence / Profile preview

Yangxin Dawaiyimisike Migao

Development stage
Unknown
Administration
Oral
01

Overview

Yangxin Dawaiyimisike Migao is a traditional Uyghur medicine formulated as a brown, viscous honey paste with a unique aroma and a sweet, slightly bitter taste. It is manufactured by Xinjiang Uygur Pharmaceutical Co., Ltd. and holds the National Medical Product Approval Number Z65020175, indicating its status as an approved pharmaceutical drug in China. The drug is composed of numerous natural ingredients, including sandalwood, red sandalwood, artificial musk, saffron, bamboo sugar, frankincense, borage flower, silkworm cocoon, pearl, agarwood, gold leaf, silver leaf, cinnamon, heguoteng, apple, emblic, dracocephalum moldavica, purslane seed, amber, usnea, centaurea cyanus root, coriander seed, rose flower, cardamom, berberis fruit, and limonium gmelinii. Traditionally, it is used to enhance the function of dominant organs, strengthen the stomach, and refresh the mind. Its primary indications include chest pain, palpitations, stomach weakness, blurred vision, and neurasthenia.

Brand names
Xipa
Other names
养心达瓦依米西克蜜膏煎膏剂
02

Targets

IL-6 (Interleukin 6)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Yangxin Dawaiyimisike Migao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangxin Dawaiyimisike Migao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call